Article info

Download PDFPDF
Polymorphic MLH1 and risk of cancer after methylating chemotherapy for Hodgkin lymphoma
  1. J M Allan, Northern Institute for Cancer Research, Paul O’Gorman Building, Medical School, Newcastle University, Framlington Place, Newcastle upon Tyne, NE2 4HH, UK; James.Allan{at}ncl.ac.uk
View Full Text

Citation

Worrillow LJ, Smith AG, Scott K, et al
Polymorphic MLH1 and risk of cancer after methylating chemotherapy for Hodgkin lymphoma

Publication history

  • Received August 14, 2007
  • Revised October 8, 2007
  • Accepted October 10, 2007
  • First published October 24, 2007.
Online issue publication 
February 29, 2008

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.